Forbes September 4, 2024
Topline
A class of drugs that includes popular medications like Ozempic, Wegovy, Rybelsus (semaglutide) or Mounjaro and Zepbound (tirzepatide) has not only proven effective in treating weight loss and diabetes: Mounting evidence suggests these drugs may be effective at treating other conditions like cancer, Alzheimer’s and COVID-19.
Key Facts
Covid-19: Semaglutide (ozempic, Wegovy, Rybelsus) Could Impact Death Rate
Although patients taking semaglutide during the COVID-19 pandemic had similar rates of COVID-19 infection compared to the placebo group, those taking the drug had a 33% lower risk of dying from coronavirus infection, researchers found.
Cardiovascular Issues: Semaglutide Drugs May Reduce Strokes, Heart Attacks
An August study found semaglutide reduces the risk of developing cardiovascular conditions like stroke and heart attack in...